HoomanPeps
← Back to catalog

Sexual health

PT-141 (Bremelanotide)

Clinically approved
4.00 reviews
Sign in to save

Primary purposes

Libido, Sexual function

Relevant conditions

Low sexual desire

Mechanism of action

Melanocortin receptor agonist (MC3R/MC4R) acting centrally on sexual desire.

Details

Bremelanotide (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Nausea is a common side effect.

Verified sources & manufacturers

Coming soon – we are building a list of verified studies and manufacturers. Learn more

Community experiences

Sign in to write reviews and share experiences.